American International Group’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-12,825
Closed -$97.3K – 1527
2024
Q1
$97.3K Buy
12,825
+77
+0.6% +$600 ﹤0.01% 2534
2023
Q4
$58K Sell
12,748
-51
-0.4% -$172 ﹤0.01% 2783
2023
Q3
$50.6K Buy
12,799
+454
+4% +$1.72K ﹤0.01% 2813
2023
Q2
$38.6K Buy
+12,345
New +$50.4K ﹤0.01% 2937
2019
Q2
– Sell
-1,620
Closed -$53K – 3137
2019
Q1
$53K Sell
1,620
-52
-3% -$2.67K ﹤0.01% 2855
2018
Q4
$99K Sell
1,672
-13
-0.8% -$1.28K ﹤0.01% 2596
2018
Q3
$236K Buy
1,685
+446
+36% +$54.1K ﹤0.01% 2331
2018
Q2
$152K Buy
+1,239
New +$105K ﹤0.01% 2531
2017
Q2
– Sell
-1,173
Closed -$66K – 3102
2017
Q1
$66K Buy
1,173
+78
+7% +$3.87K ﹤0.01% 2760
2016
Q4
$42K Sell
1,095
-3
-0.3% -$122 ﹤0.01% 2893
2016
Q3
$43.6K Buy
1,098
+2
+0.2% +$91 ﹤0.01% 2925
2016
Q2
$78.8K Buy
1,096
+291
+36% +$23K ﹤0.01% 2769
2016
Q1
$64K Hold
805
– – ﹤0.01% 3728
2015
Q4
$61K Sell
805
-1
-0.1% -$161 ﹤0.01% 3801
2015
Q3
$309K Buy
806
+1
+0.1% +$451 ﹤0.01% 2421
2015
Q2
$335K Buy
805
+443
+122% +$185K ﹤0.01% 2545
2015
Q1
$172K Hold
362
– – ﹤0.01% 3094
2014
Q4
$134K Buy
+362
New +$93.3K ﹤0.01% 3317

Other funds holding LRMR

American International Group's LRMR Position: Q2 2024 in Review

American International Group sold out of Larimar Therapeutics (LRMR) in Q2 2024, closing a stake of 12,825 shares — an estimated $97.3K sold.

American International Group first reported a position in LRMR in Q4 2014 and held it in 18 quarters. The position peaked at $335K in Q2 2015. 107 funds tracked by Wall St. Rank hold LRMR as of Q2 2024.

  • American International Group reported no remaining Larimar Therapeutics position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 12,825 Larimar Therapeutics shares in Q2 2024, an estimated $97.3K.
  • American International Group first reported a position in Larimar Therapeutics in Q4 2014 and held it in 18 quarters.
  • American International Group's Larimar Therapeutics position peaked at $335K in Q2 2015.
  • 107 funds tracked by Wall St. Rank held Larimar Therapeutics as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.